当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:200.16亿  总市值:200.16亿
流通股本:10.55亿   总股本:10.55亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,751,891,144.212,929,463,148.1211,706,028,235.718,577,455,854.54
  收到的税费返还--3,522,821.592,904,603.31
  收到其他与经营活动有关的现金93,283,141.6563,143,319.6846,748,050.14203,174,384.84
  经营活动现金流入小计5,845,174,285.862,992,606,467.811,756,299,107.448,783,534,842.69
  购买商品、接受劳务支付的现金1,315,040,484.68526,854,643.762,860,282,382.531,969,430,996.01
  支付给职工以及为职工支付的现金477,127,688.87241,722,628.451,033,775,872.62792,342,148.57
  支付的各项税费690,743,306.72364,147,684.171,422,258,079.791,050,616,577.62
  支付其他与经营活动有关的现金2,403,294,446.881,181,865,196.615,500,032,203.574,269,681,091.19
  经营活动现金流出的平衡项目000.010
  经营活动现金流出小计4,886,205,927.152,314,590,152.9910,816,348,538.528,082,070,813.39
  经营活动产生的现金流量净额958,968,358.71678,016,314.81939,950,568.92701,464,029.3
二、投资活动产生的现金流量:
  收回投资收到的现金8,800,000---
  取得投资收益收到的现金3,705,542.511,251,052.812,969,310.322,430,468.65
  处置固定资产、无形资产和其他长期资产收回的现金净额240,29092,355491,704.83403,605.15
  收到的其他与投资活动有关的现金3,093,462.11,546,364.967,535,769.775,308,128.25
  投资活动现金流入小计15,839,294.612,889,772.7710,996,784.928,142,202.05
  购建固定资产、无形资产和其他长期资产支付的现金62,977,434.9137,477,008.39196,995,309.52188,978,477.05
  投资支付的现金178,100,000302,200,00063,550,00013,750,000
  支付其他与投资活动有关的现金--3,002.36-
  投资活动现金流出小计241,077,434.91339,677,008.39260,548,311.88202,728,477.05
  投资活动产生的现金流量净额-225,238,140.3-336,787,235.62-249,551,526.96-194,586,275
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,757,5001,366,66620,890,00020,790,000
  其中:子公司吸收少数股东投资收到的现金2,757,5001,366,66620,890,00020,790,000
  取得借款收到的现金1,039,000,079624,000,0002,306,170,243.31,951,570,243.3
  收到其他与筹资活动有关的现金80,760,129.9958,028,436.721,877,453.13952,251.05
  筹资活动现金流入小计1,122,517,708.99683,395,102.722,328,937,696.431,973,312,494.35
  偿还债务支付的现金806,502,886.48309,976,632.621,806,833,413.451,296,792,211.08
  分配股利、利润或偿付利息支付的现金59,419,044.0529,779,651.85287,180,976.8252,673,485.41
  其中:子公司支付给少数股东的股利、利润--14,744,765.2813,654,028.78
  支付其他与筹资活动有关的现金125,939,959.2471,572,881.08800,133,181.83665,751,173.41
  筹资活动现金流出小计991,861,889.77411,329,165.552,894,147,572.082,215,216,869.9
  筹资活动产生的现金流量净额130,655,819.22272,065,937.17-565,209,875.65-241,904,375.55
四、汇率变动对现金及现金等价物的影响-9,965.41-42,158.2310,649.55-2,404.55
  现金及现金等价物净增加额平衡项目000.010
五、现金及现金等价物净增加额864,376,072.22613,252,858.13125,199,815.87264,970,974.2
  加:期初现金及现金等价物余额817,532,973.76817,532,973.76692,333,157.89692,333,157.89
  期末现金及现金等价物余额1,681,909,045.981,430,785,831.89817,532,973.76957,304,132.09
补充资料:
  净利润590,229,183.85--702,394,653.25-
  资产减值准备-2,601,071.04-977,512,390.37-
  固定资产和投资性房地产折旧238,530,337.57-403,681,531.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧238,530,337.57-403,681,531.89-
  无形资产摊销35,983,601.66-199,084,210.45-
  长期待摊费用摊销3,560,690.63-6,342,789.25-
  处置固定资产、无形资产和其他长期资产的损失-157,220.65--427,415.37-
  固定资产报废损失102,363.27-2,045,860.56-
  公允价值变动损失-3,377,528.63-149,331.32-
  财务费用56,721,190.73-122,063,506.17-
  投资损失-4,570,467.9--13,020,046.98-
  递延所得税60,949,217.4--40,411,704.85-
  其中:递延所得税资产减少59,565,437.4--21,131,054.45-
    递延所得税负债增加1,383,780--19,280,650.4-
  存货的减少250,177,979.49-228,759,740.31-
  经营性应收项目的减少103,427,131.93-583,885,319.81-
  经营性应付项目的增加-341,597,921.31--820,284,937.05-
  现金的期末余额1,681,909,045.98-817,532,973.76-
  减:现金的期初余额817,532,973.76-692,333,157.89-
  现金及现金等价物的净增加额864,376,072.22-125,199,815.87-
公告日期2025-08-282025-04-262025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑